SPHDF Overview
Upcoming Projects (SPHDF)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (SPHDF)
-
Assessing Catalyst Pharma's AGAMREE (Vamorolone) for Treating Duchenne Muscular Dystrophy, following the recent FDA approval
Tickers: CPRX, SPHDF, SANN.XSWX
Executed On: Nov 17, 2023 at 07:45 AM EST
Upcoming & Overdue Catalysts (SPHDF)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (SPHDF)
-
First consensus for the management of LHON using Raxone (idebenone) published in the Journal of Neuro-Ophthalmology
Ticker: SPHDF
Occurred on: Oct 23, 2017
Strategic Initiatives (SPHDF)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
